Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |